Adjuvant Therapy for Early-Stage HER2-Positive Breast Cancer

EP. 1: Adjuvant Therapy for Early-Stage HER2+ Breast Cancer

February 2nd 2018

EP. 2: The APHINITY Trial

February 2nd 2018

EP. 3: The ExteNET Trial

February 2nd 2018

EP. 4: Factors Influencing Adjuvant Therapy Use for HER2+ Breast Cancer

February 2nd 2018

EP. 5: Which Chemotherapy With Adjuvant Trastuzumab and Pertuzumab?

February 2nd 2018

EP. 6: Optimal Timing for Neratinib

February 2nd 2018

EP. 7: Diarrhea Prophylaxis With Neratinib

February 2nd 2018

EP. 8: Role for Neratinib Following Adjuvant Dual-Targeted HER2 Therapy

February 2nd 2018

EP. 9: Treating Patients with HER2+ Breast Cancer: Impact of Cost

February 2nd 2018

EP. 10: Breast Cancer: Factors to Consider for Adjuvant Therapy

February 2nd 2018

EP. 11: Adjuvant Therapy Data for HER2-Positive Breast Cancer

February 2nd 2018

EP. 12: Chemotherapy With Adjuvant Therapy in Breast Cancer

February 2nd 2018

EP. 13: Use of Neratinib in HER2-Positive Breast Cancer

February 2nd 2018

EP. 14: Breast Cancer: Extended Adjuvant Therapy and Cost Factors

February 2nd 2018

EP. 15: Treatment Landscape for HER2-Positive Breast Cancer

February 2nd 2018

EP. 16: Priority Reviews in Ovarian Cancer, Prostate Cancer, NSCLC, and More

February 2nd 2018